Physician profile
Nicholas N Desantis
NPI 1053317545
$1,620.17
in general payments reported to CMS, 2019-2025
10 companies · $548 in 2025
The $548 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.38 · 2021: $125 · 2022: $177 · 2023: $445 · 2024: $227 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,220.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $434.63 | 2021-2023 | |
| Acumed LLC | $292.16 | 2025 | Acumed |
| Nevro Corp. | $135.09 | 2023 | Senza |
| Aroa Biosurgery Incorporated | $134.26 | 2025 | |
| Trimed, INC. | $125.00 | 2024 | |
| Amgen INC. | $121.84 | 2025 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $104.62 | 2022 | |
| Smith+Nephew, INC. | $102.20 | 2024 | Collagenase Santyl |
| Melinta Therapeutics, LLC | $98.38 | 2019 | |
| Treace Medical Concepts, INC. | $71.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Desantis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.